Natalie Decker Partners with NERD Focus™ Energy Drink Ahead of Henry 180 Xfinity Series Race at Road America
30 juin 2021 11h36 HE
|
Beverage USA Holdings Inc.
FREEHOLD, N.J., June 30, 2021 (GLOBE NEWSWIRE) -- NERD Focus™, a leading focus beverage aimed at assisting in energy production and concentration, is teaming up with up-and-coming NASCAR driver...
Nerds On Site Inc. Announces Issuance of Compensation Shares
03 juin 2021 16h23 HE
|
Nerds On Site Inc.
TORONTO, June 03, 2021 (GLOBE NEWSWIRE) -- Nerds On Site Inc. (CSE: NERD) (OTCQB: NOSUF) (“NERD” or the “Company”), a mobile IT solutions company servicing Small and Medium-Sized Enterprise (SME)...
Nerds On Site Inc. Announces Stock Option Grant to Management
01 juin 2021 12h02 HE
|
Nerds On Site Inc.
TORONTO, June 01, 2021 (GLOBE NEWSWIRE) -- Nerds On Site Inc. (CSE: NERD) (OTCQB: NOSUF) (“NERD” or the “Company”), a mobile IT solutions company servicing Small and Medium-Sized Enterprise (SME)...
NERD™ Partners with New Jersey Distributor, L.J. Zucca Inc., Expanding its Mental Acuity Beverage to the Mid-Atlantic Region
20 avr. 2021 09h00 HE
|
Beverage USA Holdings Inc.
FREEHOLD, N.J., April 20, 2021 (GLOBE NEWSWIRE) -- NERD Focus™, a leading focus beverage recently acquired by BevUSA, today announces its partnership with L.J. Zucca Inc., a convenience store...
NERD™ Partners with Bill’s Distribution, Bringing its Mental Acuity Beverage to Local Grocers and Convenient Stores in Wisconsin
03 mars 2021 09h00 HE
|
Beverage USA Holdings Inc.
FREEHOLD, N.J., March 03, 2021 (GLOBE NEWSWIRE) -- NERD Focus™, a leading focus beverage recently acquired by BevUSA, today announces its expansion into Wisconsin, adding to its local availability...
Sucampo Reports Top-Line Data from Phase 2a Study of Cobiprostone in Patients with PPI-Refractory Non-Erosive Reflux Disease (NERD) and Symptomatic Gastroesophageal Reflux Disease (sGERD)
19 avr. 2016 07h00 HE
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., April 19, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced top-line data from a Phase 2a study of...